ALCEDIAG
Created in 2013
- BETA
Up & running (A)
Existing signals show a regular activity Social networks
82 2,779Activities
Technologies
Entity types
Location
Cap Delta, 1682 Rue de la Valsière, 34790 Grabels, France
Grabels
France
Employees
Scale: 11-50
Estimated: 13
SIREN
790020846Engaged corporates
11
1 11Added in Motherbase
3 years, 6 months ago
biotech Value proposition
Biomarkers for better health
Biomarker-based diagnostics for Mental Health
ALCEDIAG is a personalized medicine company specializing in the development of biological signatures aimed to serve as the basis of diagnostics tools, with a primary focus on mental health.
These biomarkers are based on the analysis of RNA editing, an epigenetic mechanism altering the nature and conformation of RNA. RNA editing may lead to the production of altered forms of proteins or modify the regulation of gene expression. RNA editing can be modified in the case of certain diseases, or as a consequence of a medical treatment.
ALCEDIAG blood biomarkers already have been proven to be related to mental health conditions such as depression and suicidal tendencies.
ALCEDIAG develops EDITDIAG, a blood test to diagnose mental disorders. EDITDIAG has already been clinically tested on hundreds of patientsand for several pathologies including depression, suicidal tendencies and bipolar disorders, showing outstanding sensitivity and specificity.
With its expertise and experience, ALCEDIAG has also developed a platform to discover new biomarkers based on RNA editing. The company uses this platform for the needs of its own tests and research and collaborates with other entities to discover biomarkers for other pathologies.
ALCEDIAG commercializes EDITOX, a predictive test to assess neuropsychiatric adverse side effects. EDITOX assesses the risk of drugs inducing severe psychiatric side effects, with a first focus on depression and suicide and then on epilepsy.
ALCEDIAG is a subsidiary of ALCEN, an industrial group active in the domains of Medical & Healthcare, Defense & Security, Aeronautics & Space, Energy and large Scientific Instrumentation.
ALCEDIAG is currently looking for partners to develop companion diagnostic tests for mental health.
Headquarters: Route des Michels CD 56, 13270 Peynier - France
R&D: Parc Euromedecine, Cap Delta, 1682 rue de la Valsière, 34184 Montpellier – France
Biotechnology, Life Sciences, psychiatry diagnostic, prediction medicine, RNA Editing, Medical Research, Personalized Medicine, Neurosciences, Mental health, CNS, and Medical diagnosticsOriginal language
Biomarkers for better health
Biomarker-based diagnostics for Mental Health
ALCEDIAG is a personalized medicine company specializing in the development of biological signatures aimed to serve as the basis of diagnostics tools, with a primary focus on mental health.
These biomarkers are based on the analysis of RNA editing, an epigenetic mechanism altering the nature and conformation of RNA. RNA editing may lead to the production of altered forms of proteins or modify the regulation of gene expression. RNA editing can be modified in the case of certain diseases, or as a consequence of a medical treatment.
ALCEDIAG blood biomarkers already have been proven to be related to mental health conditions such as depression and suicidal tendencies.
ALCEDIAG develops EDITDIAG, a blood test to diagnose mental disorders. EDITDIAG has already been clinically tested on hundreds of patientsand for several pathologies including depression, suicidal tendencies and bipolar disorders, showing outstanding sensitivity and specificity.
With its expertise and experience, ALCEDIAG has also developed a platform to discover new biomarkers based on RNA editing. The company uses this platform for the needs of its own tests and research and collaborates with other entities to discover biomarkers for other pathologies.
ALCEDIAG commercializes EDITOX, a predictive test to assess neuropsychiatric adverse side effects. EDITOX assesses the risk of drugs inducing severe psychiatric side effects, with a first focus on depression and suicide and then on epilepsy.
ALCEDIAG is a subsidiary of ALCEN, an industrial group active in the domains of Medical & Healthcare, Defense & Security, Aeronautics & Space, Energy and large Scientific Instrumentation.
ALCEDIAG is currently looking for partners to develop companion diagnostic tests for mental health.
Headquarters: Route des Michels CD 56, 13270 Peynier - France
R&D: Parc Euromedecine, Cap Delta, 1682 rue de la Valsière, 34184 Montpellier – France
ALCEDIAG | biomarkers for better health
biomarkers for better health
https://www.alcediag-alcen.com/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 BFM Business Media, Broadcast Media Production and Distribution | BFM Business Media, Broadcast Media Production and Distribution | Other 28 Mar 2024 | | |
 Ipsos France Polling institute, Research Services | Ipsos France Polling institute, Research Services | Other 21 Feb 2024 | | |
 European Parliament European Union, Political Organizations | European Parliament European Union, Political Organizations | Other 12 Jan 2024 | | |
 Bpifrance Bank, Banking | Bpifrance Bank, Banking | Other 13 Dec 2023 | | |
 La French Tech Media, Government Administration | La French Tech Media, Government Administration | Other 20 Nov 2023 | | |
 BioValley France Public business cluster, Biotechnology, French Cluster, Biotechnology Research | BioValley France Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Other 1 Jun 2023 | | |
 France Biotech Startup accelerator & VC, Biotechnology, Biotechnology Research | France Biotech Startup accelerator & VC, Biotechnology, Biotechnology Research | Other 20 Nov 2023 | | |
 McKinsey & Company Consulting, Business Consulting and Services | McKinsey & Company Consulting, Business Consulting and Services | Other 4 Oct 2022 | | |
 Medicen Paris Region Public business cluster, French Cluster, Civic and Social Organizations | Medicen Paris Region Public business cluster, French Cluster, Civic and Social Organizations | Other 1 Jun 2023 | | |
 Eurobiomed Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Eurobiomed Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Other 1 Jun 2023 | | |